What is the latest PIDILITIND stock price?
The latest stored price for PIDILITIND is Rs 1,482.00 as of 2026-10-09.
gimli
PIDILITIND stock AI analysis
PIDILITIND Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers
PIDILITE INDUSTRIES LTD is a large-cap stock in Chemicals. This Gimli page shows the latest available PIDILITIND price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
Price
₹1,482.00
1W return
+1.23%
1M return
-5.73%
3M return
-6.82%
6M return
+9.99%
1Y return
-1.88%
Market cap
₹150,834.30 cr
PE
56.83
PB
13.65
ROE
+25.27%
ROCE
+26.04%
RSI
39.99
Turnover
₹46.37 cr
Why it can matter in screens
- Momentum: PIDILITIND is below 50DMA, below 200DMA; RSI is 39.99.
- Returns: 1D +1.50%, 1W +1.23%, 1M -5.73%, 3M -6.82%, 1Y -1.88%.
- Trend levels: 52W high ₹1,707.50, 52W low ₹1,430.00, off high -13.21%.
- Liquidity: latest turnover is ₹46.37 cr; volume vs 20D is +0.48%.
- Valuation/profitability: PE 56.83, PB 13.65, ROE +25.27%, ROCE +26.04%.
- Growth: 3Y sales CAGR +7.50%, 3Y profit CAGR +24.36%.
Quick Answers
Is PIDILITIND above its 50DMA and 200DMA?
PIDILITIND is below 50DMA, below 200DMA. The latest 50DMA is 1,598.61 and the latest 200DMA is 1,499.60.
What are PIDILITIND PE, ROE and ROCE?
PIDILITIND has PE 56.83, ROE +25.27%, and ROCE +26.04% in Gimli's latest available snapshot.
How has PIDILITIND performed recently?
PIDILITIND has returned -5.73% over 1 month, -6.82% over 3 months, and -1.88% over 12 months in the latest stored data.
Is this stock page investment advice?
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
Financials and Ownership
Quarterly income statement
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-06-30 | 4,551.55 cr | 1,302.62 cr | 872.41 cr | 8.57 |
| 2026-03-31 | 3,583.38 cr | 887.63 cr | 579.27 cr | 5.69 |
| 2025-12-31 | 3,709.91 cr | 954.01 cr | 618.01 cr | 6.07 |
| 2025-09-30 | 3,605.00 cr | 900.89 cr | 584.60 cr | 5.68 |
| 2025-06-30 | 3,753.10 cr | 1,026.92 cr | 672.41 cr | 6.61 |
| 2025-03-31 | 3,141.14 cr | 687.24 cr | 422.34 cr | 4.15 |
| 2024-12-31 | 3,368.91 cr | 853.71 cr | 552.42 cr | 5.43 |
| 2024-09-30 | 3,234.91 cr | 825.71 cr | 534.56 cr | 10.51 |
Annual income statement
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 14,600.83 cr | 3,769.10 cr | 2,448.92 cr | 24.07 |
| 2025-03-31 | 13,140.31 cr | 3,231.53 cr | 2,076.24 cr | 20.41 |
| 2024-03-31 | 12,337.07 cr | 2,750.84 cr | 1,729.38 cr | 17.00 |
| 2023-03-31 | 11,751.62 cr | 2,040.62 cr | 1,273.25 cr | 12.53 |
| 2022-03-31 | 8,935.58 cr | 1,895.47 cr | 1,191.41 cr | 23.43 |
Balance sheet
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 15,432.89 cr | 232.49 cr | 417.21 cr | 11,048.65 cr |
| 2025-03-31 | 14,011.47 cr | 323.94 cr | 454.14 cr | 9,957.76 cr |
| 2024-03-31 | 12,103.95 cr | 515.14 cr | 382.47 cr | 8,617.01 cr |
| 2023-03-31 | 10,525.02 cr | 310.16 cr | 390.61 cr | 7,445.92 cr |
| 2022-03-31 | 9,515.62 cr | 352.07 cr | 415.83 cr | 6,602.61 cr |
Cash flow
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | 2,828.45 cr | 2,235.68 cr | n/a |
| 2025-03-31 | 2,286.63 cr | 1,834.29 cr | n/a |
| 2024-03-31 | 2,724.03 cr | 2,165.32 cr | n/a |
| 2023-03-31 | 1,557.57 cr | 1,052.22 cr | n/a |
| 2022-03-31 | 955.37 cr | 580.63 cr | n/a |
Shareholding Trend
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-06-30 | +69.24% | +11.69% | +9.88% | +4.33% | +9.18% | +0.00% |
| 2026-03-31 | +69.32% | +11.75% | +9.64% | +4.34% | +9.29% | +0.00% |
| 2025-12-31 | +69.33% | +12.00% | +9.26% | +4.56% | +9.41% | +0.00% |
| 2025-09-30 | +69.33% | +12.09% | +9.16% | +4.66% | +9.42% | +0.00% |
| 2025-09-24 | +69.33% | +12.17% | +9.10% | +4.61% | +9.39% | +0.00% |
| 2025-06-30 | +69.36% | +12.13% | +9.15% | +4.64% | +9.35% | +0.00% |
| 2025-03-31 | +69.50% | +11.60% | +9.43% | +4.88% | +9.47% | +0.00% |
| 2024-12-31 | +69.60% | +11.79% | +9.16% | +4.05% | +9.46% | +0.00% |
| 2024-09-30 | +69.60% | +11.96% | +8.91% | +3.62% | +9.53% | +0.00% |
| 2024-06-30 | +69.75% | +11.58% | +8.98% | +3.55% | +9.68% | +0.00% |
| 2024-03-31 | +69.77% | +11.31% | +8.94% | +3.60% | +9.98% | +0.00% |
| 2023-12-31 | +69.84% | +11.49% | +8.32% | +3.49% | +10.34% | +0.00% |
| 2023-09-30 | +69.86% | +11.44% | +8.02% | +3.57% | +10.68% | +0.00% |
| 2023-06-30 | +69.92% | +11.34% | +7.93% | +3.88% | +10.82% | +0.00% |
| 2023-03-31 | +69.94% | +10.61% | +8.47% | +4.21% | +10.98% | +0.00% |
| 2022-12-31 | +69.94% | +11.08% | +8.13% | +4.08% | +10.85% | +0.00% |
| 2022-09-30 | +69.94% | +11.34% | +7.75% | +4.04% | +10.97% | +0.00% |
| 2022-06-30 | +69.94% | +0.00% | +18.61% | n/a | n/a | +0.00% |
| 2022-03-31 | +69.94% | +0.00% | +18.87% | n/a | n/a | +0.00% |
| 2021-12-31 | +69.98% | +0.00% | +19.14% | n/a | n/a | +0.00% |
Industry Peers
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SOLARINDS | SOLAR INDUSTRIES (I) LTD | 180,980.20 cr | 90.880888 | +35.93% | +40.46% |
| SRF | SRF LTD | 74,679.49 cr | 34.546170 | +16.21% | -15.93% |
| LINDEINDIA | LINDE INDIA LIMITED | 51,136.41 cr | 93.151425 | +13.58% | -2.99% |
| COROMANDEL | COROMANDEL INTERNTL. LTD | 50,202.32 cr | 27.582629 | +14.95% | -24.08% |
| FLUOROCHEM | GUJARAT FLUOROCHEM LTD | 49,177.65 cr | 85.082436 | +7.60% | +18.12% |
| FACT | FACT LTD | 47,197.43 cr | -1191.854335 | -2.91% | -17.98% |
| NAVINFLUOR | NAVIN FLUORINE INT. LTD | 42,829.87 cr | 58.111428 | +22.33% | +82.11% |
| UPL | UPL LIMITED | 41,233.45 cr | 19.833309 | +5.26% | -27.64% |
Try these prompts
- Analyze PIDILITE INDUSTRIES with valuation, momentum and industry peers
- Compare PIDILITIND with other Chemicals stocks
- Show large-cap stocks in Chemicals above 50DMA with positive 1M return
- Find Chemicals stocks with improving momentum and reasonable valuation
Related screen ideas
- View Chemicals stocks
- View large-cap stocks
- Find stocks above 50DMA
- Compare PIDILITIND with other Chemicals stocks
Data snapshot: 2026-10-09. Not investment advice.